Trial Profile

Phase I trial of PulmoXen™ in healthy volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 09 Apr 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dornase alfa (Primary)
Indications Cystic fibrosis
Focus Adverse reactions
Sponsors Pharmasyntez

Most Recent Events

09 Apr 2014 New trial record
07 Apr 2014 Safety data from a completed phase I trial were presented in a Xenetic Biosciences media release.
17 Jul 2013 Phase I trial was to be initiated in the third quarter of 2013, according to a Pharmsynthez media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com